A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)
Conditions: Intermittent Claudication; Peripheral Artery Disease Interventions: Drug: GFH312; Other: Placebo Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials